Literature DB >> 21674575

High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa.

Francis Buadi1, Ann W Hsing, Jerry A Katzmann, Ruth M Pfeiffer, Adam Waxman, Edward D Yeboah, Richard B Biritwum, Yao Tettey, Andrew Adjei, Lisa W Chu, Angelo DeMarzo, George J Netto, Angela Dispenzieri, Robert A Kyle, S Vincent Rajkumar, Ola Landgren.   

Abstract

Chronic antigenic stimulation is associated with hypergamma-globulinemia. Higher rates of hypergamma-globulinemia in tropical populations are maintained even with migration to temperate regions. We conducted a population-based screening study to assess the prevalence and risk factors for hypergamma-globulinemia in Ghana, Africa. 917 Ghanaian males (50-74 years) underwent in-person interviews and health examinations. Serum from all persons was analyzed by electrophoresis performed on agarose gel; serum with a discrete/localized band was subjected to immunofixation. 54 persons with monoclonal proteins were excluded and 17 samples were insufficient for analysis. Using logistic regression and Chi-square statistics we analyzed patterns of hypergamma-globulinemia. Among 846 study subjects, the median γ-globulin level was 1.86 g/dL. On the basis of a U.S. reference, 616 (73%) had hypergamma-globulinemia (>1.6 g/dL) and 178 (21%) had γ-globulin levels >2.17 gm/dl. On multivariate analyses, lower education status (P = 0.0013) and never smoking (P = 0.038) were associated with increased γ-globulin levels. Self-reported history of syphilis was associated with hypergamma-globulinemia. We conclude that three quarters of this population-based adult Ghanaian male sample had hypergamma-globulinemia with γ-globulin levels >1.6 g/dL. Future studies are needed to uncover genetic and environmental underpinnings of our finding, and to define the relationship between hypergamma-globulinemia, monoclonal gammopathy of undetermined significance (MGUS), and multiple myeloma.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674575      PMCID: PMC3736856          DOI: 10.1002/ajh.22040

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  36 in total

Review 1.  The immune system. Second of two parts.

Authors:  P J Delves; I M Roitt
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

2.  Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.

Authors:  Ola Landgren; Gloria Gridley; Ingemar Turesson; Neil E Caporaso; Lynn R Goldin; Dalsu Baris; Thomas R Fears; Robert N Hoover; Martha S Linet
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

3.  Anthropometric characteristics and risk of multiple myeloma.

Authors:  Cindy K Blair; James R Cerhan; Aaron R Folsom; Julie A Ross
Journal:  Epidemiology       Date:  2005-09       Impact factor: 4.822

4.  Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies.

Authors:  Nikhil C Munshi
Journal:  Mayo Clin Proc       Date:  2007-12       Impact factor: 7.616

5.  Prevalence of polyclonal gammopathy in polyneuropathy.

Authors:  K C Gorson; A H Ropper; A K Palmetshofer; R Weinstein
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

6.  Southern community cohort study: establishing a cohort to investigate health disparities.

Authors:  Lisa B Signorello; Margaret K Hargreaves; Mark D Steinwandel; Wei Zheng; Qiuyin Cai; David G Schlundt; Maciej S Buchowski; Carolyne W Arnold; Joseph K McLaughlin; William J Blot
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

7.  Racial differences in serum immunoglobulin levels: relationship to cigarette smoking, T-cell subsets, and soluble interleukin-2 receptors.

Authors:  D J Tollerud; L M Brown; W A Blattner; S T Weiss; E M Maloney; C C Kurman; D L Nelson; R N Hoover
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

8.  Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

Authors:  V Mohamed-Ali; S Goodrick; A Rawesh; D R Katz; J M Miles; J S Yudkin; S Klein; S W Coppack
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

9.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

10.  Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.

Authors:  Ola Landgren; Jerry A Katzmann; Ann W Hsing; Ruth M Pfeiffer; Robert A Kyle; Edward D Yeboah; Richard B Biritwum; Yao Tettey; Andrew A Adjei; Dirk R Larson; Angela Dispenzieri; L Joseph Melton; Lynn R Goldin; Mary L McMaster; Neil E Caporaso; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2007-12       Impact factor: 7.616

View more
  3 in total

Review 1.  MGUS to myeloma: a mysterious gammopathy of underexplored significance.

Authors:  Madhav V Dhodapkar
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

2.  Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.

Authors:  Benjamin M Cherry; Rene Costello; Adriana Zingone; Jason Burris; Neha Korde; Elisabet Manasanch; Mary Kwok; Christina Annunziata; Mark J Roschewski; Eric A Engels; Ola Landgren
Journal:  Am J Hematol       Date:  2012-11-21       Impact factor: 10.047

Review 3.  Biological determinants of health disparities in multiple myeloma.

Authors:  Cheryl Jacobs Smith; Stefan Ambs; Ola Landgren
Journal:  Blood Cancer J       Date:  2018-08-28       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.